Andrew Slack

Andrew Slack has over 30 years of experience in the pharmaceutical and biotech industry. Andrew currently holds the position of Vice President, Business Development, Clinical Development at Pharmaron, where they are responsible for global business and sales management of the company's divisions in the US, EU, and Japan. Prior to this, Andrew served as Vice President, Business Development, Radiolabeled Sciences & Metabolism at Pharmaron. In 2011, they were Senior Director, Strategic Development at Xceleron Inc, a subsidiary of Pharmaron. Before joining Xceleron, Andrew worked as Director, Global Business Development at Intertek. Andrew has also held leadership roles at WIL Research Holding Company, Inc., Synomics Pharmaceutical Services, ClinTrials BioResearch (CTBR), Huntingdon Life Sciences, and Inveresk Research. Throughout their career, Andrew has demonstrated expertise in business development, strategic planning, marketing, and sales.

Andrew Slack attended Imperial College London from 1979 to 1983, where they obtained a BSc Hons. degree in Biochemistry with a focus on Applied Biochemistry & Biotechnology.